Provided by Tiger Trade Technology Pte. Ltd.

Insmed

127.28
-1.5200-1.18%
Post-market: 128.401.12+0.88%19:30 EDT
Volume:2.59M
Turnover:330.17M
Market Cap:27.80B
PE:-31.13
High:128.85
Open:127.22
Low:124.29
Close:128.80
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:1.28
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:36.69
PE(LYR):-19.83

Loading ...

Insmed Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

S&P 500 Futures up in Premarket Trading; BillionToOne, HubSpot Lag

Dow Jones
·
Aug 06

Insmed Surges After Q2 Revenue Beat

Reuters
·
Aug 06

Insmed Q2 FY26 Net Loss Narrows to $13.2 Million; Revenue Rises 296% to $425.5 Million

Reuters
·
Aug 06

Movement Alert|Insmed Pre-Market Rise 17.15%, Q2 Earnings Massively Beat Expectations with Near-Breakeven EPS

Market Focus
·
Aug 06

Earnings Flash (INSM) Insmed Posts Q2 Loss $0.06 a Share, vs. FactSet Est of $0.69 Loss

MT Newswires Live
·
Aug 06

Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M Estimate

Benzinga Earnings
·
Aug 06

Stock Track | Insmed Soars 14.21% in Pre-market on Q2 Revenue Beat

Stock Track
·
Aug 06

Insmed Q2 EPS USD -0.06

Reuters
·
Aug 06

Insmed : Raises FY 2026 Brinsupri Revenue Guidance to $1.25 Bln -$1.40 Bln

THOMSON REUTERS
·
Aug 06

Earning Preview: Insmed Q2 revenue expected to increase by 278%, institutions lean positive on profitability ramp

Earnings Agent
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Edwards Lifesciences (EW)

TIPRANKS
·
Jul 28

Insmed Chair and CEO William Lewis Disposes of 10,700 Common Shares Worth $1.14 Million

Reuters
·
Jul 25

Insmed to Release Q2 2026 Results, Host Investor Conference Call

Reuters
·
Jul 23

Insmed (INSM) Stock Could Be Pricey As Its 4.4x Run Continues

Simply Wall St.
·
Jul 22

Guggenheim Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
Jul 22

Ritu Baral Reaffirms Buy on Insmed, Raising Price Target from $200 to $243 Ahead of Q2 Preview

TIPRANKS
·
Jul 22

Insmed initiated with an Outperform at BMO Capital

TIPRANKS
·
Jul 21

Is Insmed (INSM) Undervalued After Positive TPIP Data Backed A Phase 3 Push?

Simply Wall St.
·
Jul 20

Insmed (INSM) Reports 12 Month TPIP Data That Sets Up Phase 3

Simply Wall St.
·
Jul 19